KDL(SH:603987) Zheng Quan Zhi Xing·2025-09-02 11:25Core Viewpoint - The report outlines a share transfer agreement where Changsha Medical Investment Co., Ltd. will acquire 21,839,544 shares of Shanghai Kangdelai Enterprise Development Group Co., Ltd., representing 5% of the total share capital, to enhance its strategic positioning in the healthcare industry [1][5][7]. Group 1: Share Transfer Details - The share transfer agreement was signed on September 2, 2025, with the transfer price set at RMB 10.81 per share, totaling RMB 236,085,470.64 [7][8]. - Following the transfer, Changsha Medical Investment Co., Ltd. will hold a total of 28,157,644 shares, increasing its ownership from 1.45% to 6.45% of the total shares [7][15]. - The transfer is subject to compliance confirmation from the Shanghai Stock Exchange and subsequent registration with the China Securities Depository and Clearing Corporation [2][11]. Group 2: Purpose and Future Plans - The purpose of this equity change is to deepen the strategic layout of the company and achieve a win-win situation through strategic collaboration in the healthcare sector [5][6]. - There are currently no plans for Changsha Medical Investment Co., Ltd. to increase or decrease its shareholding in the next 12 months, aside from this agreement [5][15]. Group 3: Company Information - Changsha Medical Investment Co., Ltd. is a limited liability company with a registered capital of RMB 100 million, primarily engaged in investment activities and various sales [4][5]. - The major shareholder of Changsha Medical Investment Co., Ltd. is Zhang Min, holding 90% of the shares [4][5].